An investigation of misoprostol in the promotion of wound healing

Summary

Misoprostol is a synthetic analogue of prostaglandin E1 that is known to attenuate the inflammatory process and promote collagen formation by inhibiting IL-1 and TNF. The objective of this study was to determine if the application of misoprostol wound powder to open wounds in dogs would modulate inflammation and decrease wound healing time. This prospective randomized study included 20 dogs with 281 surgically cre0ated 8 mm open wounds over the dorsum. The wounds were assigned to one of three treatments: control (no treatment), treatment (misoprostol powder with ‘avicel’), or vehicle (‘avicel’ alone). Open wounds were digitally photographed on days zero, one, three, seven, 10, and 15 to measure wound size. All wounds were harvested at day 15 and evaluated histologically for evidence of edema, inflammation, necrosis, and collagen characteristics. Amount of epithelialization of open wounds was not significantly different among the groups at days three, seven, 10, and 15. The vehicle treated wounds were found to have a significantly higher degree of necrosis in comparison to control and treatment wounds. The control wounds had significantly lower scores for deep inflammation. All of the other parameters evaluated including location of wound, oedema, and characteristics of collagen fibres in the wound showed no significance among groups. However, the total wound score for the misoprostol was statistically higher than that for the control wounds. Therefore the value of using misoprostol wound powder with ‘avicel’ as the vehicle to enhance wound healing cannot be substantiated by the results of this study.

Keywords

Wound healing - pathology-skin - misoprostol

• References

• 1 Canapp SO, Farese JP. Schultz et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg 2003; 32: 515-23.
• 2 Alam R, DeJarnatt A, Stafford S. et al. Misoprostol inhibits the cutaneous late-phase allergic response to antigens. Results of a double-blind placebo-controlled randomized study and an investigation into the mechanism of action. Am J Ther 1995; 2: 749-54.
• 3 Doube A, Davies J, Notarianni L. et al. Effect of misoprostol on concentrations of prostaglandins in synovial fluid. Ann Rheum Dis 1991; 50: 797-9.
• 4 Goszcz A, Bieron K, Grodzinska L. Misoprostol as agonist of IP2 receptor. J Physiol Pharmacol 2002; 53: 635-41.
• 5 Mertz-Nielsen A, Eskerod O, Bukhave K. et al. Misoprostol inhibits gastric mucosal release of endogenous prostaglandin E2 and thromboxane B2 inhealthyvolunteers. Gut 1995; 36: 511-5.
• 6 Rossetti RG, Seiler CM, Brathwaite K. et al. Effect of misoprostol on acute and chronic inflammation. Am J Ther 1995; 2: 600-6.
• 7 Smallwood JI, Malawista SE. Misoprostol stimulates cAMP generation in human leukocytes: synergy with colchicines suggests anew potential for established drugs. Am J Ther 1995; 2: 725-9.
• 8 Wiederkehr JC, Dumble L, Pollak R. et al. Immunosuppressive effect of misoprostol: a new synthetic prostaglandin E! analogueue. Aust N Z J Surg 1990; 60: 121-4.
• 9 Bauer RF. Misoprostol preclinical pharmacology. DigDisSci 1985; 30: 118S-125S.
• 10 Dajani EZ. Overviewofthe mucosal protective effects ofmisoprostol in man. Prostaglandins 1987; 33 Suppl 117-29.
• 11 Dorta G, Nicolet M. Vouillamoz et al. Effects of misoprostol on healing and prevention of biopsy induced gastroduodenal lesions occurring during the administration of diclofenac to volunteers. Aliment Pharmacol Ther 1996; 10: 563-9.
• 12 Goodlad RA, Madgwick AJ, Moffatt MR. et al. Prostaglandins and the gastric epithelium: effects of misoprostol on gastric epithelial cell proliferation in the dog. Gut 1989; 30: 316-21.
• 13 Herting RL, Nissen CH. Overview ofmisoprostol clinical experience. Dig Dis Sci 1986; 31: 47S-54S.
• 14 Shield MJ. Novel applications of misoprostol. PharmacTher 1995; 65: 125-47.
• 15 Hanson WR, Marks JE, Reddy SP. etal. Protection from radiation-induced oral mucositis by misoprostol, a prostaglandin E! analogue: a placebo-controlled, double-blind clinical trial. Am J Ther 1995; 2: 850-7.
• 16 Marks SC, Miller SC. Local delivery of prostaglandin E! induces periodontal ligament regeneration in adult dogs. J Periodont Res 1994; 29: 103-8.
• 17 Marks SC, Miller SC. Local infusion of prostaglandin E! stimulates mandibular bone formation in vivo. J Oral Pathol 1988; 17: 500-5.
• 18 Trombelli L, Lee MB, Promsudthi A. et al. Periodontal repair in dogs: histologic observations of guided tissue regeneration with a prostaglandin E₁ analogue/methacrylate composite. J Clin Periodontal 1999; 26: 381-7.
• 19 Pajulo Q, Viljanto J, Lonnberg B. et al. Viscose cellulose sponge as an implantable matrix: changes in the structure increase the production of granulation tissue. J Biomed Mater Res 1996; 32: 439-46.
• 20 Swaim SF, Henderson RA. Wound healing. In: Small animal wound management. Baltimore: Williams & Wilkins; 1997: 1-12 53-86.
• 21 Johnston DE. The healing process of open skin wounds. Compend Contin Educ Pract Vet 1979; 1: 789.
• 22 Mison MB, Steficek B, Lavagnino M. et al. Comparison of the effects of the CO2 surgical laser and conventional surgical techniques on healing and wound tensile strength of skin flaps in the dog. Vet Surg 2003; 32: 153-60.
• 23 Johnston DE. The process of wound healing. JAm AnimHosp Assoc 1977; 13: 186.
• 24 Bauer MS, Aiken SE. The healing of open wounds. Semin Vet Med Surg (Small Animal) 1989; 4: 268-73.
• 25 Pavletic MM. Basic principles of wound healing and management. In: Atlas ofsmall animal reconstructive surgery. Philadelphia: WB Saunders; 1999: 11-40.
• 26 Totsuka E, Todo S, Zhu Y. et al. Attenuation of ischemic liver injury by prostaglandin E! analogueue, misoprostol, and prostaglandin i! analogueue, OP-41483. J Am Coll Surg 1998; 187: 276-86.
• 27 Doheny JG, Jervis EJ, Guarna MM. et al. Cellulose as an inert matrix for presenting cytokines to target cells: production and properties of a stem cell factor-cellulose-binding domain fusion protein. Biochem J 1999; 339: 429-34.
• 28 Henderson WJ, Melville-Jones C, Barr WT. et al. Identification of talc on surgeon's gloves and in tissue from starch granulomas. Br J Surg 1975; 62: 941-4.
• 29 Sheikh KMA, Duggal K, Relfson M. et al. An experimental histopathologic study ofsurgical glove powders. Arch Surg 1984; 119: 215-9.